• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

痴呆路易体和阿尔茨海默病患者的临床特征与脑脊液生物标志物的关联存在差异。

Differential associations of clinical features with cerebrospinal fluid biomarkers in dementia with Lewy bodies and Alzheimer's disease.

机构信息

Department of Neurology and Neurosurgery, Escola Paulista de Medicina, Federal University of São Paulo (UNIFESP), Rua Botucatu 740, Vila Clementino, São Paulo, SP, 04023-900, Brazil.

Department of Biophysics, Escola Paulista de Medicina, Federal University of São Paulo (UNIFESP), São Paulo, SP, Brazil.

出版信息

Aging Clin Exp Res. 2023 Aug;35(8):1741-1752. doi: 10.1007/s40520-023-02452-5. Epub 2023 Jun 2.

DOI:10.1007/s40520-023-02452-5
PMID:37264166
Abstract

AIM

To explore associations of cerebrospinal fluid biomarkers of neurodegeneration and amyloidosis with caregiver burden, cognition and functionality in dementia with Lewy bodies (DLB) paired with late-onset Alzheimer's disease (AD) and healthy older people.

METHODS

Consecutive outpatients with DLB were matched with outpatients with AD according to sex, cognitive scores and dementia stage, and with cognitively healthy controls according to age and sex to investigate associations of cerebrospinal fluid amyloid-β (Aβ,Aβ,Aβ), tau, phospho-tau Thr, ubiquitin, α-synuclein and neurofilament light with caregiver burden, functionality, reverse digit span, a clock drawing test, Mini-Mental State Examination (MMSE) and Severe MMSE, adjusted for sex, age, education, dementia duration and APOE-ε4 alleles.

RESULTS

Overall, 27 patients with DLB (78.98 ± 9.0 years-old; eleven APOE-ε4 +) were paired with 27 patients with AD (81.50 ± 5.8 years-old; twelve APOE-ε4 +) and 27 controls (78.98 ± 8.7 years-old; four APOE-ε4 +); two-thirds were women. In AD, Aβ/Aβ and Aβ were lower, while tau/Aβ and phospho-tau Thr/Aβ were higher; α-synuclein/Aβ was lower in DLB and higher in AD. The following corrected associations remained significant: in DLB, instrumental functionality was inversely associated with tau/phospho-tau Thr and tau/Aβ, and reverse digit span associated with α-synuclein; in AD, instrumental functionality was inversely associated with neurofilament light, clock drawing test scores inversely associated with phospho-tau Thr/Aβ and α-synuclein/Aβ, and Severe MMSE inversely associated with tau/Aβ and tau/phospho-tau Thr.

CONCLUSIONS

Cerebrospinal fluid phospho-tau Thr in DLB was similar to AD, but not Aβ. In associations with test scores, biomarker ratios were superior to isolated biomarkers, while worse functionality was associated with axonal degeneration only in AD.

摘要

目的

探讨与神经退行性变和淀粉样变性相关的脑脊液生物标志物与路易体痴呆(DLB)患者的照料者负担、认知和功能之间的关系,这些患者与晚发性阿尔茨海默病(AD)和健康老年人相匹配。

方法

连续入组 DLB 门诊患者,根据性别、认知评分和痴呆阶段与 AD 门诊患者相匹配,并根据年龄和性别与认知健康对照相匹配,以调查脑脊液 Aβ(Aβ)、tau、磷酸化 tau Thr、泛素、α-synuclein 和神经丝轻链与照料者负担、功能、倒数数字广度、时钟绘制测试、简易精神状态检查(MMSE)和严重 MMSE 之间的关系,这些因素调整了性别、年龄、教育、痴呆持续时间和 APOE-ε4 等位基因。

结果

总体而言,27 例 DLB 患者(78.98±9.0 岁;11 例 APOE-ε4+)与 27 例 AD 患者(81.50±5.8 岁;12 例 APOE-ε4+)和 27 例对照(78.98±8.7 岁;4 例 APOE-ε4+)相匹配;三分之二为女性。在 AD 中,Aβ/Aβ 和 Aβ 降低,而 tau/Aβ 和磷酸化 tau Thr/Aβ 升高;α-synuclein/Aβ 在 DLB 中降低,在 AD 中升高。以下校正后的关联仍然显著:在 DLB 中,工具性功能与 tau/phospho-tau Thr 和 tau/Aβ 呈负相关,倒数数字广度与 α-synuclein 呈正相关;在 AD 中,工具性功能与神经丝轻链呈负相关,时钟绘制测试评分与 phospho-tau Thr/Aβ 和 α-synuclein/Aβ 呈负相关,严重 MMSE 与 tau/Aβ 和 tau/phospho-tau Thr 呈负相关。

结论

DLB 中的脑脊液磷酸化 tau Thr 与 AD 相似,但与 Aβ 不同。在与测试评分的关联中,生物标志物比值优于单独的生物标志物,而较差的功能仅与 AD 中的轴突变性相关。

相似文献

1
Differential associations of clinical features with cerebrospinal fluid biomarkers in dementia with Lewy bodies and Alzheimer's disease.痴呆路易体和阿尔茨海默病患者的临床特征与脑脊液生物标志物的关联存在差异。
Aging Clin Exp Res. 2023 Aug;35(8):1741-1752. doi: 10.1007/s40520-023-02452-5. Epub 2023 Jun 2.
2
Associations of Neuropsychiatric Features with Cerebrospinal Fluid Biomarkers of Amyloidogenesis and Neurodegeneration in Dementia with Lewy Bodies Compared with Alzheimer's Disease and Cognitively Healthy People.路易体痴呆与阿尔茨海默病及认知健康人群相比,神经精神特征与淀粉样蛋白生成和神经退行性变的脑脊液生物标志物的相关性。
J Alzheimers Dis. 2021;81(3):1295-1309. doi: 10.3233/JAD-210272.
3
Amyloid-β peptides in cerebrospinal fluid of patients with dementia with Lewy bodies.路易体痴呆患者脑脊液中的淀粉样β肽。
Alzheimers Res Ther. 2019 Oct 10;11(1):83. doi: 10.1186/s13195-019-0537-5.
4
Diagnostic Value of Cerebrospinal Fluid Biomarkers (Phospho-Tau181, total-Tau, Aβ42, and Aβ40) in Prodromal Stage of Alzheimer's Disease and Dementia with Lewy Bodies.脑脊液生物标志物(磷酸化tau181、总tau、Aβ42 和 Aβ40)在阿尔茨海默病和路易体痴呆前驱期的诊断价值。
J Alzheimers Dis. 2016;51(4):1069-83. doi: 10.3233/JAD-150731.
5
Differential role of CSF fatty acid binding protein 3, α-synuclein, and Alzheimer's disease core biomarkers in Lewy body disorders and Alzheimer's dementia.脑脊液脂肪酸结合蛋白 3、α-突触核蛋白与阿尔茨海默病核心生物标志物在路易体疾病和阿尔茨海默病痴呆中的差异作用。
Alzheimers Res Ther. 2017 Jul 28;9(1):52. doi: 10.1186/s13195-017-0276-4.
6
Association of Plasma Amyloid, P-Tau, GFAP, and NfL With CSF, Clinical, and Cognitive Features in Patients With Dementia With Lewy Bodies.血浆淀粉样蛋白、P-tau、GFAP 和 NfL 与路易体痴呆患者脑脊液、临床和认知特征的关联。
Neurology. 2024 Jun 25;102(12):e209418. doi: 10.1212/WNL.0000000000209418. Epub 2024 Jun 3.
7
Cerebrospinal Fluid Alzheimer's Disease Biomarkers Across the Spectrum of Lewy Body Diseases: Results from a Large Multicenter Cohort.路易体疾病谱系中的脑脊液阿尔茨海默病生物标志物:一项大型多中心队列研究结果
J Alzheimers Dis. 2016 Aug 18;54(1):287-95. doi: 10.3233/JAD-160322.
8
Cerebrospinal fluid Alzheimer biomarkers can be useful for discriminating dementia with Lewy bodies from Alzheimer's disease at the prodromal stage.脑脊液阿尔茨海默病生物标志物有助于在疾病前驱期鉴别路易体痴呆与阿尔茨海默病。
J Neurol Neurosurg Psychiatry. 2018 May;89(5):467-475. doi: 10.1136/jnnp-2017-316385. Epub 2018 Jan 10.
9
CSF amyloid β38 as a novel diagnostic marker for dementia with Lewy bodies.脑脊液淀粉样蛋白 β38 作为路易体痴呆的新型诊断标志物。
J Neurol Neurosurg Psychiatry. 2011 Feb;82(2):160-4. doi: 10.1136/jnnp.2009.199398. Epub 2010 Nov 3.
10
Differential levels of alpha-synuclein, beta-amyloid42 and tau in CSF between patients with dementia with Lewy bodies and Alzheimer's disease.路易体痴呆和阿尔茨海默病患者脑脊液中α-突触核蛋白、β-淀粉样蛋白 42 和 tau 的差异水平。
J Neurol Neurosurg Psychiatry. 2010 Jun;81(6):608-10. doi: 10.1136/jnnp.2009.197483.

引用本文的文献

1
Changes in Daily Functioning in Association With Tau and Amyloid Among Unimpaired Older Adults With and Without Elevated Amyloid.在无认知障碍的老年人中,伴有和不伴有淀粉样蛋白升高情况下,日常功能变化与tau蛋白和淀粉样蛋白的关系。
Neurology. 2025 Jun 24;104(12):e213775. doi: 10.1212/WNL.0000000000213775. Epub 2025 May 29.
2
Research on the perspectives of people affected by dementia with Lewy bodies: a scoping review.路易体痴呆症患者视角的研究:一项范围综述
Alzheimers Res Ther. 2025 May 26;17(1):117. doi: 10.1186/s13195-025-01760-4.
3
Lewy Body Dementia Research in Latin America: A Scoping Review.

本文引用的文献

1
Visuospatial memory impairment as a potential neurocognitive marker to predict tau pathology in Alzheimer's continuum.视空间记忆损伤作为预测阿尔茨海默病连续体中 tau 病理学的潜在神经认知标志物。
Alzheimers Res Ther. 2021 Oct 9;13(1):167. doi: 10.1186/s13195-021-00909-1.
2
Apolipoprotein E4, amyloid, and cognition in Alzheimer's and Lewy body disease.载脂蛋白 E4、淀粉样蛋白与阿尔茨海默病和路易体病的认知。
Neurobiol Aging. 2021 Oct;106:45-54. doi: 10.1016/j.neurobiolaging.2021.06.004. Epub 2021 Jun 12.
3
Harmonizing neuropsychological assessment for mild neurocognitive disorders in Europe.
拉丁美洲的路易体痴呆症研究:一项范围综述。
Mov Disord Clin Pract. 2025 Apr 21. doi: 10.1002/mdc3.70059.
4
Cerebrospinal fluid and blood neurofilament light chain in Parkinson's disease and atypical parkinsonian syndromes: a systematic review and Bayesian network meta-analysis.帕金森病和非典型帕金森综合征中的脑脊液和血液神经丝轻链:系统评价和贝叶斯网络荟萃分析
J Neurol. 2025 Apr 3;272(4):311. doi: 10.1007/s00415-025-13051-x.
5
The problem of multiple adjustments in the assessment of minimal clinically important differences.最小临床重要差异评估中的多重调整问题。
Alzheimers Dement (N Y). 2025 Jan 3;11(1):e70032. doi: 10.1002/trc2.70032. eCollection 2025 Jan-Mar.
6
Anthropometric and Demographic Features Affect the Interpretation of Cerebrospinal Fluid Biomarkers in Patients with Different Dementia Syndromes and Cognitively Healthy Adults.人体测量学和人口统计学特征会影响不同痴呆综合征患者和认知正常成年人的脑脊液生物标志物的解读。
Neuromolecular Med. 2024 Nov 1;26(1):43. doi: 10.1007/s12017-024-08810-4.
7
Behavioral disorders in dementia with Lewy bodies: old and new knowledge.路易体痴呆中的行为障碍:新旧知识
J Neural Transm (Vienna). 2025 Feb;132(2):203-216. doi: 10.1007/s00702-024-02823-w. Epub 2024 Sep 6.
协调欧洲轻度神经认知障碍的神经心理学评估。
Alzheimers Dement. 2022 Jan;18(1):29-42. doi: 10.1002/alz.12365. Epub 2021 May 13.
4
Associations of Neuropsychiatric Features with Cerebrospinal Fluid Biomarkers of Amyloidogenesis and Neurodegeneration in Dementia with Lewy Bodies Compared with Alzheimer's Disease and Cognitively Healthy People.路易体痴呆与阿尔茨海默病及认知健康人群相比,神经精神特征与淀粉样蛋白生成和神经退行性变的脑脊液生物标志物的相关性。
J Alzheimers Dis. 2021;81(3):1295-1309. doi: 10.3233/JAD-210272.
5
The prevalence and co-incidence of geriatric syndromes in older patients with early-stage Alzheimer's disease and dementia with Lewy bodies.老年痴呆症和路易体痴呆症早期患者老年综合征的患病率和共存率。
Aging Clin Exp Res. 2021 Sep;33(9):2599-2603. doi: 10.1007/s40520-020-01774-y. Epub 2021 Jan 28.
6
Longitudinal pathways of cerebrospinal fluid and positron emission tomography biomarkers of amyloid-β positivity.脑脊髓液和正电子发射断层扫描生物标志物的淀粉样蛋白-β阳性的纵向途径。
Mol Psychiatry. 2021 Oct;26(10):5864-5874. doi: 10.1038/s41380-020-00950-w. Epub 2020 Dec 11.
7
Untangling the association of amyloid-β and tau with synaptic and axonal loss in Alzheimer's disease.厘清阿尔茨海默病中淀粉样蛋白-β和 tau 与突触和轴突丢失的关联。
Brain. 2021 Feb 12;144(1):310-324. doi: 10.1093/brain/awaa395.
8
AD-Related CSF Biomarkers Across Distinct Levels of Cognitive Impairment: Correlations With Global Cognitive State.与认知障碍不同程度相关的 AD 相关 CSF 生物标志物:与整体认知状态的相关性。
J Geriatr Psychiatry Neurol. 2021 Nov;34(6):659-667. doi: 10.1177/0891988720944237. Epub 2020 Aug 6.
9
Neuropsychiatric feature profiles of patients with Lewy body dementia.路易体痴呆患者的神经精神特征谱。
Clin Neurol Neurosurg. 2020 Jul;194:105832. doi: 10.1016/j.clineuro.2020.105832. Epub 2020 Apr 8.
10
Sex-specific associations with cerebrospinal fluid biomarkers in dementia with Lewy bodies.性别特异性与路易体痴呆症患者脑脊液生物标志物的相关性。
Alzheimers Res Ther. 2020 Apr 17;12(1):44. doi: 10.1186/s13195-020-00610-9.